Global PD-L1 Biomarker Testing Market Insights, Forecast to 2030

Publication ID:

PB508244010

Publication Date:

August 2, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 4,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

PD-L1 Biomarker Testing measures the amount of PDL1 on cancer cells. PDL1 is a protein that helps keep immune cells from attacking nonharmful cells in the body. Normally, the immune system fights foreign substances like viruses and bacteria, and not your own healthy cells. Some cancer cells have high amounts of PDL1. This allows the cancer cells to "trick" the immune system, and avoid being attacked as foreign, harmful substances.
Current PD-L1 testing is based on immunohistochemistry (IHC) methods. Immunohistochemistry (IHC) is the process whereby antibodies are used to detect proteins (antigens) in cells within a tissue section (for instance liver, pancreas or the heart).
PD-L1 is a ligand that binds to PD-1 (programmed cell death-1), expressed on activated T cells, to evade anti-tumor responses. PD-L1 plays a role in inhibiting T cell activation and proliferation and has emerged as an important target in cancer treatment. PD-L1 protein detection by immunohistochemistry (IHC) testing is widely used as a predictive biomarker assay for anti鈥揚D-1/PD-L1 therapies.
PDL1 testing is used to find out if you have a cancer that may benefit from immunotherapy.
Market Analysis and Insights: Global PD-L1 Biomarker Testing Market
The global PD-L1 Biomarker Testing market is projected to grow from US$ 2088 million in 2024 to US$ 14870 million by 2030, at a Compound Annual Growth Rate (CAGR) of 38.7% during the forecast period.
The classification of PD-L1 Biomarker Testing includes PD-L1 (22C3), PD-L1 (28-8), PD-L1 (SP142), PD-L1 (SP263) and Other, and the revenue proportion of PD-L1 (22C3) in 2019 is about 21.68%.
PD-L1 Biomarker Testing is widely used in Hospital and Diagnostic Laboratories. The most proportion of PD-L1 Biomarker Testing is Hospital, and the proportion in 2019 is about 52.7%.
North Americas is the largest consumption place, with a consumption market share nearly 55.63% in 2019. Following North Americas, Europe is the second largest consumption place with the consumption market share of 26.7%.
Report Covers:
This report presents an overview of global market for PD-L1 Biomarker Testing market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of PD-L1 Biomarker Testing, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for PD-L1 Biomarker Testing, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the PD-L1 Biomarker Testing revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global PD-L1 Biomarker Testing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for PD-L1 Biomarker Testing revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
Agilent Technologies
Roche
Segment by Type
PD-L1 (22C3)
PD-L1(28-8)
PD-L1 (SP142)
PD-L1 (SP263)
Other
Segment by Application
Hospital
Diagnostic Center
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of PD-L1 Biomarker Testing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of PD-L1 Biomarker Testing companies鈥� competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, PD-L1 Biomarker Testing revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global PD-L1 Biomarker Testing Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 PD-L1 (22C3)
1.2.3 PD-L1(28-8)
1.2.4 PD-L1 (SP142)
1.2.5 PD-L1 (SP263)
1.2.6 Other
1.3 Market by Application
1.3.1 Global PD-L1 Biomarker Testing Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Diagnostic Center
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global PD-L1 Biomarker Testing Market Perspective (2019-2030)
2.2 Global PD-L1 Biomarker Testing Growth Trends by Region
2.2.1 PD-L1 Biomarker Testing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 PD-L1 Biomarker Testing Historic Market Size by Region (2019-2024)
2.2.3 PD-L1 Biomarker Testing Forecasted Market Size by Region (2025-2030)
2.3 PD-L1 Biomarker Testing Market Dynamics
2.3.1 PD-L1 Biomarker Testing Industry Trends
2.3.2 PD-L1 Biomarker Testing Market Drivers
2.3.3 PD-L1 Biomarker Testing Market Challenges
2.3.4 PD-L1 Biomarker Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue PD-L1 Biomarker Testing by Players
3.1.1 Global PD-L1 Biomarker Testing Revenue by Players (2019-2024)
3.1.2 Global PD-L1 Biomarker Testing Revenue Market Share by Players (2019-2024)
3.2 Global PD-L1 Biomarker Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of PD-L1 Biomarker Testing, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global PD-L1 Biomarker Testing Market Concentration Ratio
3.4.1 Global PD-L1 Biomarker Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by PD-L1 Biomarker Testing Revenue in 2023
3.5 Global Key Players of PD-L1 Biomarker Testing Head office and Area Served
3.6 Global Key Players of PD-L1 Biomarker Testing, Product and Application
3.7 Global Key Players of PD-L1 Biomarker Testing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 PD-L1 Biomarker Testing Breakdown Data by Type
4.1 Global PD-L1 Biomarker Testing Historic Market Size by Type (2019-2024)
4.2 Global PD-L1 Biomarker Testing Forecasted Market Size by Type (2025-2030)
5 PD-L1 Biomarker Testing Breakdown Data by Application
5.1 Global PD-L1 Biomarker Testing Historic Market Size by Application (2019-2024)
5.2 Global PD-L1 Biomarker Testing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America PD-L1 Biomarker Testing Market Size (2019-2030)
6.2 North America PD-L1 Biomarker Testing Market Size by Type
6.2.1 North America PD-L1 Biomarker Testing Market Size by Type (2019-2024)
6.2.2 North America PD-L1 Biomarker Testing Market Size by Type (2025-2030)
6.2.3 North America PD-L1 Biomarker Testing Market Share by Type (2019-2030)
6.3 North America PD-L1 Biomarker Testing Market Size by Application
6.3.1 North America PD-L1 Biomarker Testing Market Size by Application (2019-2024)
6.3.2 North America PD-L1 Biomarker Testing Market Size by Application (2025-2030)
6.3.3 North America PD-L1 Biomarker Testing Market Share by Application (2019-2030)
6.4 North America PD-L1 Biomarker Testing Market Size by Country
6.4.1 North America PD-L1 Biomarker Testing Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America PD-L1 Biomarker Testing Market Size by Country (2019-2024)
6.4.3 North America PD-L1 Biomarker Testing Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe PD-L1 Biomarker Testing Market Size (2019-2030)
7.2 Europe PD-L1 Biomarker Testing Market Size by Type
7.2.1 Europe PD-L1 Biomarker Testing Market Size by Type (2019-2024)
7.2.2 Europe PD-L1 Biomarker Testing Market Size by Type (2025-2030)
7.2.3 Europe PD-L1 Biomarker Testing Market Share by Type (2019-2030)
7.3 Europe PD-L1 Biomarker Testing Market Size by Application
7.3.1 Europe PD-L1 Biomarker Testing Market Size by Application (2019-2024)
7.3.2 Europe PD-L1 Biomarker Testing Market Size by Application (2025-2030)
7.3.3 Europe PD-L1 Biomarker Testing Market Share by Application (2019-2030)
7.4 Europe PD-L1 Biomarker Testing Market Size by Country
7.4.1 Europe PD-L1 Biomarker Testing Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe PD-L1 Biomarker Testing Market Size by Country (2019-2024)
7.4.3 Europe PD-L1 Biomarker Testing Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China PD-L1 Biomarker Testing Market Size (2019-2030)
8.2 China PD-L1 Biomarker Testing Market Size by Type
8.2.1 China PD-L1 Biomarker Testing Market Size by Type (2019-2024)
8.2.2 China PD-L1 Biomarker Testing Market Size by Type (2025-2030)
8.2.3 China PD-L1 Biomarker Testing Market Share by Type (2019-2030)
8.3 China PD-L1 Biomarker Testing Market Size by Application
8.3.1 China PD-L1 Biomarker Testing Market Size by Application (2019-2024)
8.3.2 China PD-L1 Biomarker Testing Market Size by Application (2025-2030)
8.3.3 China PD-L1 Biomarker Testing Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia PD-L1 Biomarker Testing Market Size (2019-2030)
9.2 Asia PD-L1 Biomarker Testing Market Size by Type
9.2.1 Asia PD-L1 Biomarker Testing Market Size by Type (2019-2024)
9.2.2 Asia PD-L1 Biomarker Testing Market Size by Type (2025-2030)
9.2.3 Asia PD-L1 Biomarker Testing Market Share by Type (2019-2030)
9.3 Asia PD-L1 Biomarker Testing Market Size by Application
9.3.1 Asia PD-L1 Biomarker Testing Market Size by Application (2019-2024)
9.3.2 Asia PD-L1 Biomarker Testing Market Size by Application (2025-2030)
9.3.3 Asia PD-L1 Biomarker Testing Market Share by Application (2019-2030)
9.4 Asia PD-L1 Biomarker Testing Market Size by Region
9.4.1 Asia PD-L1 Biomarker Testing Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia PD-L1 Biomarker Testing Market Size by Region (2019-2024)
9.4.3 Asia PD-L1 Biomarker Testing Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America PD-L1 Biomarker Testing Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America PD-L1 Biomarker Testing Market Size by Type
10.2.1 Middle East, Africa, and Latin America PD-L1 Biomarker Testing Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America PD-L1 Biomarker Testing Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America PD-L1 Biomarker Testing Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America PD-L1 Biomarker Testing Market Size by Application
10.3.1 Middle East, Africa, and Latin America PD-L1 Biomarker Testing Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America PD-L1 Biomarker Testing Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America PD-L1 Biomarker Testing Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America PD-L1 Biomarker Testing Market Size by Country
10.4.1 Middle East, Africa, and Latin America PD-L1 Biomarker Testing Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America PD-L1 Biomarker Testing Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America PD-L1 Biomarker Testing Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Agilent Technologies
11.1.1 Agilent Technologies Company Details
11.1.2 Agilent Technologies Business Overview
11.1.3 Agilent Technologies PD-L1 Biomarker Testing Introduction
11.1.4 Agilent Technologies Revenue in PD-L1 Biomarker Testing Business (2019-2024)
11.1.5 Agilent Technologies Recent Developments
11.2 Roche
11.2.1 Roche Company Details
11.2.2 Roche Business Overview
11.2.3 Roche PD-L1 Biomarker Testing Introduction
11.2.4 Roche Revenue in PD-L1 Biomarker Testing Business (2019-2024)
11.2.5 Roche Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

Agilent Technologies
Roche

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂